Routine Helicobacter pylori Screening Post-Myocardial Infarction: Insights from the HELP-MI SWEDEHEART Trial
Highlights
- Routine Helicobacter pylori (H. pylori) screening during hospitalization for myocardial infarction (MI) did not significantly decrease the incidence of upper gastrointestinal bleeding (UGIB).
- Approximately 70% of patients were screened, with a 23.6% positivity rate for H. pylori infection.
- Subgroup analyses indicated potential benefits of screening in patients with anemia and those with impaired kidney function.
- Current evidence advises against universal H. pylori screening post-MI, but targeted risk-stratified screening strategies may be warranted.
Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.